Molina Other Liab vs Non Currrent Assets Other Analysis
MOH Stock | USD 297.90 1.30 0.44% |
Molina Healthcare financial indicator trend analysis is infinitely more than just investigating Molina Healthcare recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Molina Healthcare is a good investment. Please check the relationship between Molina Healthcare Other Liab and its Non Currrent Assets Other accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molina Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Molina Stock please use our How to Invest in Molina Healthcare guide.
Other Liab vs Non Currrent Assets Other
Other Liab vs Non Currrent Assets Other Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Molina Healthcare Other Liab account and Non Currrent Assets Other. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Molina Healthcare's Other Liab and Non Currrent Assets Other is 0.93. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Molina Healthcare, assuming nothing else is changed. The correlation between historical values of Molina Healthcare's Other Liab and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Molina Healthcare are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Other Liab i.e., Molina Healthcare's Other Liab and Non Currrent Assets Other go up and down completely randomly.
Correlation Coefficient | 0.93 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Other Liab
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Most indicators from Molina Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Molina Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molina Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Molina Stock please use our How to Invest in Molina Healthcare guide.As of now, Molina Healthcare's Selling General Administrative is increasing as compared to previous years. The Molina Healthcare's current Sales General And Administrative To Revenue is estimated to increase to 0.1, while Tax Provision is projected to decrease to under 233.1 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 3.3B | 3.9B | 4.3B | 4.6B | Total Revenue | 27.8B | 32.0B | 34.1B | 35.8B |
Molina Healthcare fundamental ratios Correlations
Click cells to compare fundamentals
Molina Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Molina Healthcare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.8B | 9.5B | 12.2B | 12.3B | 14.9B | 15.6B | |
Short Long Term Debt Total | 1.5B | 4.8B | 2.4B | 2.4B | 2.4B | 2.5B | |
Other Current Liab | 2.5B | 1.3B | 5.8B | 5.6B | 6.5B | 6.8B | |
Total Current Liabilities | 3.3B | 5.0B | 7.0B | 6.9B | 8.2B | 8.6B | |
Total Stockholder Equity | 2.0B | 2.1B | 2.6B | 3.0B | 4.2B | 4.4B | |
Net Debt | (966M) | (1.8B) | (2.0B) | (1.6B) | (2.5B) | (2.3B) | |
Cash | 2.5B | 4.2B | 4.4B | 4.0B | 4.8B | 5.1B | |
Other Assets | 198M | 324M | 497M | 581M | (43M) | (40.9M) | |
Cash And Short Term Investments | 4.4B | 6.0B | 7.6B | 7.5B | 9.1B | 9.6B | |
Common Stock Shares Outstanding | 64.2M | 59.9M | 58.6M | 58.5M | 58.1M | 51.5M | |
Liabilities And Stockholders Equity | 6.8B | 9.5B | 12.2B | 12.3B | 14.9B | 15.6B | |
Other Stockholder Equity | 175M | 199M | 236M | 328M | 410M | 333.3M | |
Total Liab | 4.8B | 7.4B | 9.6B | 9.4B | 10.7B | 11.2B | |
Total Current Assets | 6.0B | 7.9B | 10.1B | 10.1B | 12.5B | 13.2B | |
Short Term Debt | 18M | 2.7B | 35M | 41M | 20M | 19M | |
Other Liab | 42M | 77M | 140M | 27M | 31.1M | 29.5M | |
Retained Earnings | 1.8B | 1.9B | 2.4B | 2.8B | 3.9B | 4.1B | |
Accounts Payable | 455M | 641M | 842M | 889M | 1.3B | 1.3B | |
Long Term Debt | 1.2B | 2.1B | 2.2B | 2.2B | 2.2B | 2.3B | |
Non Current Liabilities Total | 1.6B | 2.5B | 2.5B | 2.5B | 2.6B | 2.7B | |
Other Current Assets | 2.1B | 2.1B | 3.4B | 277M | 331M | 521.9M | |
Intangible Assets | 29M | 249M | 270M | 275M | 208M | 120.3M | |
Property Plant Equipment | 380M | 372M | 396M | 259M | 297.9M | 215.8M | |
Property Plant And Equipment Net | 385M | 391M | 396M | 259M | 313M | 232.2M | |
Non Current Assets Total | 820M | 1.7B | 2.1B | 2.2B | 2.4B | 2.5B | |
Non Currrent Assets Other | 105M | 119M | 179M | 81M | 55M | 104.9M | |
Short Term Investments | 1.9B | 1.9B | 3.2B | 3.5B | 4.3B | 4.5B | |
Property Plant And Equipment Gross | 385M | 391M | 1.0B | 954M | 999M | 1.0B | |
Net Receivables | 1.4B | 1.7B | 2.2B | 2.3B | 3.1B | 3.3B | |
Accumulated Other Comprehensive Income | (8M) | 4M | 37M | (160M) | (82M) | (77.9M) | |
Current Deferred Revenue | 249M | 375M | 370M | 359M | 418M | 438.9M | |
Net Tangible Assets | 1.8B | 1.2B | 1.4B | 1.6B | 1.8B | 1.1B | |
Retained Earnings Total Equity | 1.8B | 1.9B | 2.4B | 2.8B | 3.2B | 3.4B | |
Long Term Debt Total | 1.2B | 2.1B | 2.4B | 2.4B | 2.7B | 2.9B | |
Capital Surpluse | 175M | 199M | 236M | 328M | 295.2M | 370.5M |
Currently Active Assets on Macroaxis
When determining whether Molina Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Molina Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Molina Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Molina Healthcare Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molina Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Molina Stock please use our How to Invest in Molina Healthcare guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molina Healthcare. If investors know Molina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molina Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.342 | Earnings Share 19.66 | Revenue Per Share 649.831 | Quarterly Revenue Growth 0.174 | Return On Assets 0.069 |
The market value of Molina Healthcare is measured differently than its book value, which is the value of Molina that is recorded on the company's balance sheet. Investors also form their own opinion of Molina Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Molina Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molina Healthcare's market value can be influenced by many factors that don't directly affect Molina Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molina Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Molina Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molina Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.